Literature DB >> 4944422

Metabolic modification of Parkinson's disease and of chronic manganese poisoning.

G C Cotzias, P S Papavasiliou, J Ginos, A Steck, S Düby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4944422     DOI： 10.1146/annurev.me.22.020171.001513

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN： 0066-4219            Impact factor:   13.739


× No keyword cloud information.
  16 in total

1.  Neurochemical changes in rats chronically treated with a high concentration of manganese chloride.

Authors:  J C Lai; A W Chan; T K Leung; M J Minski; L Lim
Journal:  Neurochem Res       Date:  1992-09       Impact factor: 3.996

2.  Effects of chronic manganese treatment on rat brain regional sodium-potassium-activated and magnesium-activated adenosine triphosphatase activities during development.

Authors:  J C Lai; T K Leung; L Lim; A W Chan; M J Minski
Journal:  Metab Brain Dis       Date:  1991-09       Impact factor: 3.584

3.  Opposing effects of dopaminergic to cholinergic compounds on a cerebral dopamine-activated adenylate cyclase.

Authors:  L C Tang; G C Cotzias
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

4.  Ontogenetic exposure of rats to pre- and post-natal manganese enhances behavioral impairments produced by perinatal 6-hydroxydopamine.

Authors:  Przemysław Nowak; Kamila Bojanek; Ryszard Szkilnik; Jadwiga Jośko; Dariusz Boroń; Marta Adwent; Piotr Gorczyca; Richard M Kostrzewa; Ryszard Brus
Journal:  Neurotox Res       Date:  2010-04-06       Impact factor: 3.911

5.  Phenothiazine melanosis in schizophrenic patients.

Authors:  A H Robins
Journal:  Psychopharmacologia       Date:  1972

6.  Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.

Authors:  U K Rinne; V Sonninen; T Sirtola
Journal:  Z Neurol       Date:  1972

7.  Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.

Authors:  J R Bianchine; L Sunyapridakul
Journal:  Drugs       Date:  1973       Impact factor: 9.546

Review 8.  Clinical pharmacokinetics of anti-parkinsonian drugs.

Authors:  J M Cedarbaum
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

Review 9.  Manganese in enteral and parenteral nutrition.

Authors:  R M Leach
Journal:  Bull N Y Acad Med       Date:  1984-03

10.  Prolongation of the life-span in mice adapted to large amounts of L-dopa.

Authors:  G C Cotzias; S T Miller; A R Nicholson; W H Maston; L C Tang
Journal:  Proc Natl Acad Sci U S A       Date:  1974-06       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.